relapse

Showing 26 - 50 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

Completed
  • Hematologic Malignancies
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
Dec 3, 2021

Hodgkin Lymphoma, Adult, Relapse, Refractory Hodgkin Lymphoma Trial in Tianjin (PD-1 inhibitor)

Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • PD-1 inhibitor
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 14, 2021

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

Recruiting
  • Acute Leukemia
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 30, 2021

Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Oct 28, 2021

Schizophrenia, Mental Disorder, Educational Problems Trial in Bordeaux (Psychoeducation)

Recruiting
  • Schizophrenia
  • +7 more
  • Psychoeducation
  • Bordeaux, France
    Centre Hospitalier Charles PERRENS
Aug 17, 2021

Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

Not yet recruiting
  • Engraft Failure
  • +2 more
  • (no location specified)
Jun 22, 2021

Relapse, Quality of Life, Complication Trial in Caen, Saint-Lô (Ingrown toenails with surgery with chemical cauterisation,

Unknown status
  • Relapse
  • +3 more
  • Ingrown toenails with surgery with chemical cauterisation
  • Ingrown toenails with only surgery
  • Caen, Normandie, France
  • +1 more
Jun 9, 2021

Alcohol Use Disorder, Stress Reaction, Social Stress Trial in Mannheim (Trier Social Stress Test, Ergometer, Barlab-Exposure)

Recruiting
  • Alcohol Use Disorder
  • +6 more
  • Trier Social Stress Test
  • +3 more
  • Mannheim, Baden-Württemberg, Germany
    Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische G
Apr 21, 2021

Ketamine IV Classic Protocol : Five Years Follow up

Completed
  • Major Depressive Disorder
  • +3 more
  • Non
  • Tel HaShomer, Israel
    The Chaim Sheba Medical Center
Mar 30, 2021

Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)

Unknown status
  • Wilms Tumor
  • +2 more
  • P53, Ki67 and Cyclin A IHC.
  • Mansoura, Dakahlia, Egypt
    Mansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021

After Surgical Treatment for GERD

Completed
  • Patient Satisfaction
  • +3 more
  • 10 years follow up
  • Stockholm, Region Stockholm, Sweden
    Ersta Hospital
Feb 3, 2021

Dual-target CAR-T Cells, B ALL, Relapse Trial in Shenzhen (Dual target CAR-T cell therapy)

Unknown status
  • Dual-target CAR-T Cells
  • +3 more
  • Dual target CAR-T cell therapy
  • Shenzhen, Guangdong, China
    Shenzhen University General hospital
Jan 23, 2021

Heroin Addiction, Relapse Trial in Xi'an (Repetitive transcranial magnetic stimulation)

Unknown status
  • Heroin Addiction
  • Relapse
  • Repetitive transcranial magnetic stimulation
  • Xi'an, Shaanxi, China
    Tangdu Hospital
Jan 20, 2021

Relapse Trial in Aarhus, Oslo (Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer)

Active, not recruiting
  • Relapse
  • Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer
  • Aarhus, Denmark
  • +1 more
Dec 17, 2020

Lymphoma, Relapse Trial in France (Lenalidomide, Rituximab)

Completed
  • Lymphoma
  • Relapse
  • Clermont-Ferrand, Auvergne, France
  • +11 more
Dec 14, 2020

Different Antiviral Regimens for Hepatitis C Virus Relapse

Unknown status
  • Hepatitis C
  • +2 more
  • directly acting antivirals
  • Alexandria, Egypt
    Alexandria University.
Dec 4, 2020

Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)

Recruiting
  • Hematological Malignancies
  • +2 more
  • T-reg depleted DLI
  • Standard DLI
  • Creteil, France
    Henri Mondor Hospital
Nov 19, 2020

Interferon-A-2B, Relapse, Prevention Trial in Beijing (Interferon-alpha)

Withdrawn
  • Interferon-A-2B
  • +3 more
  • Beijing, China
    Peking University People's Hospital
Sep 21, 2020

Cognitive Impairment, Relapse, Bipolar Disorder Trial in Guangzhou (Repetitive Transcranial Magnetic Stimulation, Sham

Completed
  • Cognitive Impairment
  • +2 more
  • Repetitive Transcranial Magnetic Stimulation
  • Sham repetitive transcranial magnetic stimulation
  • Guangzhou, Guangdong, China
    Guangzhou Brain hospital(Guangzhou Huiai Hospital)
Apr 23, 2020

Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Beijing (donor lymphocyte

Unknown status
  • Donor Lymphocyte Infusion
  • +5 more
  • donor lymphocyte infusion
  • Beijing, Beijing, China
    Peking University Institute of Hematology,Beijing
Mar 9, 2020

Hodgkin Lymphoma in First Complete Remission

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Standard cohort: Clinical lab follow-up
  • Imaging cohort: integrated imaging follow-up
  • (no location specified)
Mar 4, 2020

Minimal Residual Disease, Donor Lymphocyte Infusion, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (donor

Completed
  • Minimal Residual Disease
  • +3 more
  • donor lymphocyte infusion
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 24, 2020

Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • +2 more
  • Paris, France
    Hôpital Saint-Antoine - Service de Neurologie
Jan 27, 2020

Malaria, Vivax Malaria, Relapse Trial in Khun Han (Primaquine)

Recruiting
  • Malaria
  • +3 more
  • Khun Han, Thailand
    Khun Han Hospital
Jan 10, 2020